Recipharm's solid dose facility located in Fontaine, France, has been approved for supply of manufactured products to the Japan's pharmaceuticals market following a recent inspection by the PMDA, the Japanese drug agency.

The product dossier was presented by an existing contract manufacturing customer, also securing regulatory approval for its supply to Japan.

The Fontaine site is one of Recipharm's solid dose forms site and until 2009 was owned by Solvay Pharma (now Abbott). The facility is also approved to supply to the US. In addition to manufacturing, the site also has a distribution centre for delivery to pharmacy level within France.